Effects of alpha-synuclein on dopamine and serotonin transporters
ePoster
Vienna, Austria
We use cookies for analytics.
Seminar, Hosted by Ad hoc
Professor of Pathology and Neuroscience, University of Wisconsin-Madison
Alpha synuclein and Lrrk2 are key players in Parkinson's disease and related disorders, but their normal role has been confusing and controversial. Data from acute gene-editing based knockdown, followed by functional assays, will be presented.